Inflammatory bowel diseases, or IBD, such as ulcerative colitis, are intractable diseases with unknown etiology. The number of patients with IBD in Japan has tremendously increased in recent years. However, there are no definitive treatments at present. Recently, the dysfunction of the intestinal mucosal barrier has been thought to be one of the causes for IBD. Indeed, in genetically-modified mice in which the mucosal barrier is defective, intestinal bacteria invade the colonic mucosa, and this causes high susceptibility to intestinal inflammation.